Streszczenie
4/2022
vol. 17
Artykuł oryginalny
Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
- Harvard Medical School, Boston, MA, USA
- Loyola University Medical Center, Chicago, IL, USA
- University of Massachusetts, Worchester, MA, USA
- McMaster University, Hamilton, ON, Canada
- Albany Medical Center, Albany, NY, USA
- Nishter Medical College, Multan, Pakistan
- Central Michigan University, Saginaw, MI, USA
- Wayne State University, Detroit, MI, USA
- Stanford University, Stanford, CA, USA
Gastroenterology Rev 2022; 17 (4): 288–300
Data publikacji online: 2022/01/05
Dostępne w
Indeksowane w
Zintergrowane z
